Home › Stocks › AVLN › Changes

Who bought & sold AVLN (Q2 2026)

Funds holding (Q2 2026)94
New positions94
Added0
Reduced0
Exited0

As of Q2 2026, 94 institutional funds reported holding AVLN (AVALYN PHARMACEUTICALS INC): 94 opened new positions, 0 added, 0 trimmed and 0 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (20 of 94)

Fund Shares Value Weight
Fidelity Management & Research (FMR) New 5.84M $192.10M 0.0
Novo Holdings A/S New 3.88M $127.84M 7.4
SR ONE CAPITAL MANAGEMENT, LP New 3.31M $108.92M 10.5
PERCEPTIVE ADVISORS LLC New 2.68M $88.07M 1.4
MONTANOVA CAPITAL, LLC New 2.50M $82.40M 1.5
NVP Associates, LLC New 2.27M $74.68M 22.8
WELLINGTON MANAGEMENT GROUP LLP New 2.20M $72.49M 0.0
PRICE T ROWE ASSOCIATES INC /MD/ New 1.74M $57.12M 0.0
Catalio Capital Management, LP New 1.68M $55.17M 10.4
T. Rowe Price Investment Management, Inc. New 1.60M $52.76M 0.0
EVENTIDE ASSET MANAGEMENT, LLC New 1.38M $45.28M 0.6
Bellevue Group AG New 1.35M $44.44M 0.9
BlackRock Inc New 977.26K $32.17M 0.0
Pivotal bioVenture Partners Investment Advisor LLC New 966.79K $31.83M 10.3
Citadel Advisors New 959.10K $31.57M 0.0
Andera Partners New 929.82K $30.61M 14.8
JENNISON ASSOCIATES LLC New 812.75K $26.76M 0.0
BRAIDWELL LP New 801.39K $26.38M 1.0
TPG GP A, LLC New 773.07K $25.45M 0.5
VANGUARD CAPITAL MANAGEMENT LLC New 739.77K $24.35M 0.0

Added to positions (0)

No adds this quarter.

Reduced positions (0)

No trims this quarter.

Exited positions (0)

No exits this quarter.